Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet: The Game-Changer In Diabetes Management
06:38am, Saturday, 18'th Mar 2023
Insulet achieved another remarkable fiscal year, driven by the successful adoption of Omnipod 5, which is being used by growing diabetic patients globally. The management expects continued growth in i
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
02:29pm, Thursday, 16'th Mar 2023
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Silicon Valley Bank out of S&P 500 index; Insulet selected to replace it
06:09pm, Friday, 10'th Mar 2023
S&P Indices said late Friday that Insulet Corp. PODD, -0.97% will replace Silicon Valley Bank parent SVB Financial Group SIVB, -60.41% in the S&P 500 index SPX, -1.45% at the open on Wednesday. The ba
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:19pm, Tuesday, 28'th Feb 2023
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Insulet (PODD) Upgraded to Buy: What Does It Mean for the Stock?
01:33pm, Tuesday, 28'th Feb 2023
Insulet (PODD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Insulet (PODD) Q4 Earnings Beat Estimates, Margins Down
01:33pm, Friday, 24'th Feb 2023
Insulet's (PODD) Q4 performance benefits from record quarterly U.S. and Total Omnipod new customer starts.
Insulet Corporation (PODD) Q4 2022 Earnings Call Transcript
08:59pm, Thursday, 23'rd Feb 2023
Insulet Corporation (NASDAQ:PODD ) Q4 2022 Results Conference Call February 23, 2023 4:30 PM ET Company Participants Deborah Gordon - VP, IR Jim Hollingshead - President, CEO Wayde McMillan - EVP, CFO
Insulet (PODD) Q4 Earnings and Revenues Beat Estimates
06:49pm, Thursday, 23'rd Feb 2023
Insulet (PODD) delivered earnings and revenue surprises of 129.17% and 11.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insulet: Enthusiasm Might Be Too High
06:38pm, Tuesday, 14'th Feb 2023
Insulet Corporation has been a long-term steady growth play in the diabetes delivery space. I like the strong secular growth, but margins and dilution mean that the share price advancement has far out
Insulet to Present at Upcoming Investor Conferences
06:00am, Tuesday, 14'th Feb 2023
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
The 7 Best Tech Stocks to Buy for February 2023
03:37pm, Thursday, 09'th Feb 2023
Tech stocks continue to be a major player in the stock market in 2023. Driven by ongoing innovation and investment, big-name turnarounds suggest that Feb. could be the beginning of a sharp upward tren
Insulet Has Potential To Gain More Than Analysts Are Forecasting
02:01am, Thursday, 19'th Jan 2023
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range.
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
06:00am, Thursday, 12'th Jan 2023
ACTON, Mass.--( BUSINESS WIRE )--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announce
These Are 5 Of The Best Stocks To Buy And Watch Now
09:00am, Tuesday, 03'rd Jan 2023
Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?
Insulet: Omnipod 5 Driving Revenue - But Expenses Elevated
04:41am, Tuesday, 03'rd Jan 2023
Omnipod 5 has been a major revenue catalyst for Insulet since its release. At the same time, operating expenses associated with Omnipod 5 are higher because of demand exceeding expectations.
